With this acquisition, Nemera establishes an operational footprint in Brazil and expands its product and services offering to better serve the pharmaceutical industry in Latin America.
Nemera today announced that they have entered into an agreement to acquire Milfra. Milfra, based in Jaguariuna, state of São Paulo, Brazil, specializes in the development and production of both vaginal and rectal applicators, as well as oral dosers for the pharmaceutical industry. A family-owned company founded in 1966. Milfra is known for its expertise in high quality and high volume moulding and assembly of devices and applicators.
This strategic acquisition expands Nemera’s global footprint in Latin America, extends its product offering and provides a foundation for future contract manufacturing services; thereby reinforcing its overall commitment to serving local markets. By integrating a key applicator pure player, Nemera will now be able to address specific patient and customer needs in the fields of gynaecology and urology in Brazil.
Nemera has appointed Roberto Restivo as the General Manager of the new Nemera manufacturing facility in Brazil. As a seasoned international leader, Roberto brings in a wealth of experience in several industry sectors, including medical, plastics and aerospace. Roberto has held management positions with responsibility for a wide range of fields including sales & business development, finance, industrial operations and strategy & acquisitions. Roberto, supported by the previous family owners will ensure a smooth transition with Milfra’s existing
the leadership team and he will continue to develop and grow the local Nemera team and business in the future.
Marc Hämel, CEO of Nemera said, “This acquisition opens up new opportunities for Nemera in Brazil and Latin America in general. It will enable us to better understand and serve even more patients with different needs. We feel privileged by the opportunity to integrate a new and unique culture into our already international company. Despite the tough sanitary situation and the restrictions to travel, we have already established a very good relationship with the Milfra leadership team and we have a very good feeling about their strong company culture and expertise.”
“Since we began our first discussions with the Nemera team, I was convinced that becoming part of the Nemera family was the perfect match for Milfra. We fully align with Nemera’s vision of becoming the most patient-centric drug-device solutions company in the world. After a long history of manufacturing in Brazil it is fantastic to enable Nemera to operate in Brazil.” added Francisco Pofirio, owner of Milfra.
About Milfra
Founded in 1966, in the city of Santo André, SP, Milfra became one of the leading manufacturers of electro-mechanical devices for OEM manufacturers for audio and video equipment. With the changes in market dynamics in the 2000s the family decided to leverage Milfra’s advanced manufacturing capabilities – in particular in tool making and injection moulding knowhow – to service the pharmaceutical packaging industry, with a strong focus on vaginal applicators. It has quickly become the leader in the segment.
In 2007 Milfra successfully expanded its product portfolio with a complete line of oral dosers. In 2020 Milfra launched a new line of products, including droppers, even with the challenges brought by the pandemic. The focus on quality and automation has led Milfra to become a leader in this market, always focused on how to best meet the specific needs of its customers.
About Nemera
As a world-leading drug delivery device solutions company, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint to market of their combination products. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards. Agile and open minded, we work with our customers as colleagues. Together, we go the extra mile to fulfil our mission.
For more information, visit www.nemera.net